Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1384-1389

  Conant, Katherine ^a   Ma, Methui ^b   Nath, Avindra ^b   Major, Eugene O ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSACTIVATOR PROTEIN;

ARTICLE; ASTROCYTE; CELL GROWTH; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN SYNTHESIS;

EID: 0030040212     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1384-1389.1996     Document Type: Article

References (80)

1. Adachi, A., H. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986 Production of acquired immunodeficiency syndrome-associated retrovirus, in human and nonhuman cells transfected with an infectious molecular clone. S. Virol. 59:284-291.
2. Alcami, J., T. Lain de Lera, L. Folgueira, M. A. Pedraza, J. M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, and R. B. Gaynor. 1995. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560
3. Aloisi, F., G. Borsellino, P. Samoggia, U. Testa, C. Chelucci, G. Russo, C. Peschle, and G. Levi. 1992. Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J. Neurosci Res. 32:494-506.
4. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
5. Arima, N., J. A. Molitor, M. R. Smith, J. H. Kim, Y. Daitoku, and W. C. Greene. 1991. Human T-cell leukemia virus type 1 tax induces expression of the Rel-related family of κB enhancer-binding proteins: evidence for a pretranslational component of regulation. J. Virol. 65:6892-6899.
6. Arya, S. K., C. Guo, S. F. Josephs, and F. Wong-Staal. 1985. Trans activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69-73
7. Atwood, W., C. Tornatore, R. Traub, K. Conant, and E. Major. 1994. Stimulation of HIV-1 gene expression and induction of NF-κB (p50/p65) in TNF-alpha treated human fetal glial cells. AIDS Res. Human Retroviruses 10:1207-1211.
8. Bagasra, O., K. Khalili, T. Seshamma, J. P. Taylor, and R. J. Pomerantz. 1992. TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J Virol 66:7522-7528.
9. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993 The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci USA 90:7941-7945.
10. Beckmann, R., C. Lindschau, H. Haller, F. Hucho, and K. Buchner. 1994. Differential nuclear localization of protein kinase C isoforms in neuroblastoma x glioma hybrid cells. Eur. J. Biochem. 222:335-343.
11. Benos, D. J., B. H. Hahn, J. K. Bubein, S. K. Ghosh, N. A. Mashburn, M. A. Chaikin, G. M. Shaw, and E. N. Benveniste. 1994. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc. Natl Acad. Sci. USA 91:494-498.
12. Bessho, R., K. Matsubara, M. Kubota, K. Kuwakado, A. Hirota, V. Wakazono, Y. W. Lin, A. Okuda, M. Kawai, R. Nishikomori, and T. Heike. 1994. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 48:1883-1889.
13. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
14. Brake, D. A., C. Debouck, and G. Biesecker. 1990. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein. Tat J. Cell Biol. 111:1275-1281.
15. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
16. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-alpha. Proc. Natl. Acad. Sci. USA 90:2532-2536.
17. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66:7159-7167.
18. Chen, S. J., E. Klann, M. C. Gower, C. M. Powell, J. S. Sessoms, and J. D. Sweatt. 1993. Studies with synthetic peptide substrates derived from the neuronal protein neurogramn reveal structural determinants of potency and selectivity for protein kinase C Biochemistry 32:1032-1039.
19. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
20. Cohen, D. I., Y. Tani, H. Tian, E. Boone, S. E. Samelson, and H. C. Lane. 1992. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science 256:542-545.
21. Conant, K., W. J. Atwood, R. Traub, C. S. Tornatore, and E. O. Major. 1994. An increase in p50/p65 NF-κB binding to the HIV-1 LTR is not sufficient to increase viral gene expression in the primary human astrocyte. Virology 205:586-590
22. Dayton, A., J. Sodroski, C. Rosen, W. Goh, and W. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941-947
23. Diaz-Meco, M. T., E. Berra, M. M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diaz-Golpe, M. T. Lain de Lera, J. Alcami, and C. V. Paya. 1993. A dominant negative protein kinase C ζ subspecies blocks NF-κB activation. Mol. Cell. Biol. 13:4770-4775
24. Diaz-Meco, M. T., I. Dominguez, L. Sanz, P. Dent, J. Lozano, M. M. Munincio, E. Berra, R. T. Hay, T. W. Sturgill, and J. Moscat. 1994. Zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J. 13:2842-2848
25. Dressler, K. A., M. Shalini, and R. N. Kolesnick. 1992. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell free system. Science 255:1715-1718.
26. Elder, G. A., and E. O. Major. 1988. Early appearance of type II astrocytes in developing human fetal brain. Brain Res. 470:146-150.
27. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990 Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 345:84-86.
28. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfleld, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277-287.
29. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H.-K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (London) 371:674-680.
30. Finco, T. S., A. A. Beg, and A. S. Baldwin. 1994. Inducible phosphorylation of IκBa is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors Proc. Natl. Acad. Sci. USA 91:11884-11888.
31. Flores, S. C., J. C. Marecki, K. P. Harper, S. K. Bose, S. K. Nelson, and J. M. McCord. 1993. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl Acad. Sci. USA 90:7632-7636.
32. Frankel, A. D. 1992. Activation of HIV-1 transcription by Tat. Curr. Opin Genet. Dev 2:293-298.
33. Gonzalez, A., E. Klann, J. S. Sessoms, and S. J. Chen. 1993. Use of the synthetic peptide neurogranin(28-43) as a selective protein kinase C substrate in assays of tissue homogenates. Anal. Biochem. 215:184-189
34. Goodnight, J. A., H. Mischak, W. Kolch, and J. F. Mushinski. 1995. Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. isoform-specific association with microfilaments. Golgi. endoplasmic reticulum, and nuclear and cell membranes J. Biol. Chem. 270:9991-10001.
35. Grabarck, J., and J. A. Ware. 1993. Protein kinase C activation without membrane contact in platelets stimulated by bryostatin. J. Biol. Chem 268: 5543-5549
36. Grilli, M., J. S. Chin, and M. J. Lenardo. 1993 NF-κB and Rel: participants in a multiform transcriptional regulatory system. International Rev. Cytol. 143:1-62.
37. Guy, G. R., C. M. Bunee, J. Gordon, R. H. Michell, and G. Brown. 1985 A combination of calcium ionophore and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulates the growth of purified resting B cells Scand J Immunol. 22:591-596
38. Hery, C., G. Sebire, S. Peudenier, and M. Tardieu. 1995. Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J. Neuroimmunol. 57:101-109.
39. Hidaka, H., S. Inagiki, S. Kawamote, and Y. Sasaki. 1984. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:1400-1402.
40. Jaken, S., K. Leach, and T. Klauck. 1989. Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts. J. Cell Biol 109:697-704.
41. Kanno, T., G. Franzoso, and U. Siebenlist. 1994. Human T-cell leukemia virus type 1 Tax-protein-mediated activation of NF-κB from p100(NF-κB2)-inhibited cytoplasmic reservoirs. Proc. Natl. Acad. Sci USA 91:12634-12638.
42. Knox, K. A., M. Finney, A. E. Milner, C. D. Gregory, M. J. Wakelam, R. H. Michell, and J. Gordon. 1992 Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines. Int. J. Cancer 52:959-966.
43. Koong, A. C., E. Y. Chen, N. F. Mivechi, N. C. Dennko, P. Stambrook, and A. J. Giaccia. 1994. Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve Map kinase (ERK1 or ERK2). Cancer Res 54:5273-5279.
44. Li, C. J., D. J. Frieman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science 268:429-431.
45. Lindholm, P. F., R. L. Reid, and J. N. Brady. 1992. Extracellular Tax 1 protein stimulates tumor necrosis factor beta and immunoglobulin kappa light-chain expression in lymphoid cells. J. Virol. 66:1294-1302.
46. Liu, J., N. D. Perkins, R. M. Schmid, and G. J. Nabel. 1992. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription J. Virol. 66:3883-3887.
47. Lotz, M., I. Clark-Lewis, and V. Ganu. 1994. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chon-drocytes. J. Cell Biol. 124:365-371.
48. 47a Ma, M., and A. Nath. Unpublished data
49. Machleidt, T., K. Wiegmann, T. Henkel, S. Schutze, P. Baeuerle, and M. Kronke. 1994. Sphingomyelinase activates proteolytic IκB-a degradation in a cell-free system J. Biol. Chem. 269:13760-13765.
50. Magnuson, D. S., B. E. Knudsen, J. D. Geiger, R. M. Brownstone, and A. Nath. 1995. Human immunodeficiency virus type 1 tat activates non-n-methyl-d-aspartamate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37:373-380
51. Mann, D. A., and A. D. Frankel. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1733-1739
52. McConkey, D. J., P. Hartzell, J. F. Amador-Perez, S. Orrenius, and M. Jondal. 1989 Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex J. Immunol 143:1801-1806.
53. McConkey, D. J., P. Hartzell, M. Jondal, and S. Orrenius. 1989. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol Chem 264:13399-13402
54. Meiehle, A., S. Schutze, G. Hensel, D. Brunsing, and M. Kronke. 1990 Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor. J Biol. Chem. 265:8339-8343.
55. Milani, D., G. Zauli, L. M. Neri, M. Marchisio, M. Previati, and S. Capitani. 1993. Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen Virol 74:2587-2594.
56. Nath, A., K. Psooy, C. Martin, B. Knudsen, D. S. K. Magnuson, N. Haughey, and J. D. Geiger. 1996. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic J. Virol. 70:1475-1450
57. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-634.
58. Ojeda, F., H. Folch, M. I. Guarda, B. Jastorff, and H. A. Diehl. 1995. Induction of apoptosis in thymocytes - new evidence for an interaction of PKC and PKA pathways. Biol. Chem Hoppe-Seyler 376:389-393.
59. Rautonen, J., N. Rautonen, N. L. Martin, and D. W. Wara. 1994. HIV type 1 tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res. Human Retroviruses 10:781-785.
60. Roulston, A., P. Beauparlant, N. Rice, and J. Hiscott. 1993 Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-κB/rel DNA binding activities in myelomonoblastic cells. J. Virol. 67:5235-5246.
61. Roulston, A., M. D'Addario, F. Boulerice, S. Caplan, M. A. Wainberg, and J. Hiscott. 1992. Induction of monocytic differentiation and NF-κB-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J Exp. Med 175:751-763
62. Sabatier, J., E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, and E. Bahraoui. 1991. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol. 65:961-967.
63. -2-phosphatidylserine-dependent protein kinase C in subcellular fractions and lamellar bodies of adult rabbit lung. Life Sci. 55:1129-1137.
64. Seals, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta. 1994. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp Med. 179:961-971
65. Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (London) 372:786-791.
66. Schreck, R., and P. A. Baeuerle. 1994 Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol. 234:151-163.
67. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp Med. 175:1181-1194
68. Schutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. 1992 TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced acidic sphingomyelin breakdown Cell 71:765-776.
69. Sen, R., and D. Baltimore. 1986. Inducibilty of κ immunoglobulin enhancer-binding protein NF-κB by a post translational mechanism. Cell 47:921-928.
70. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
71. Sodroski, J., W. Coh, C. Rosen, A. Dayton, E. Terwilliger, and W. Haseltine. 1986 A second post-transcriptional trans-activator gene required for HTLV-III replication Nature (London) 321:412-417.
72. Tornatore, C. S., A. Nath, K. Amemiya, and E. O. Major. 1991. Persistent human immunodeficiency virus type 1 infection in human glial cells reactivated by T-cell factors or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65:6094-6100.
73. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C J. Biol. Chem. 266:15771-15781.
74. Tranque, P. A., R. Calle, F. Naftolin, and R. Robbins. 1992 Involvement of protein kinase C in the mitogenic effect of insulin-like growth factor-1 on rat astrocytes Endocrinology 131:1948-1954.
75. 5 integrin to the basic domain of the HIV-1 Tat protein and vitronectin. J. Cell Biol 121:461-468.
76. Vogel, J., S. H. Hinrichs, L. A. Napolitano, L. Ngo, and G. Jay. 1991. Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene Cancer Res. 51:6686-6690.
77. Vogel, J., S. H. Hinrichs, R. K. Reynolds, P. A. Luciw, and G. Jay. 1988 The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (London) 335:606-611.
78. Whisler, R. L., M. A. Goyette, I. S. Grants, and Y. G. Newhouse. 1995. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells. Arch. Biochem. Biophys 319:23-35.
79. Yong, V. W. 1992. Proliferation of human and mouse astrocytes in vitro: signaling through the protein kinase C pathway. J. Neurol. Sci. 111:92-103.
80. Zauli, G., D. Gibellini, D. Milani, M. Mazzoni, P. Borgatti, M. La Placa, and S. Capitani. 1993. Human immunodeficiency type 1 Tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis Cancer Res 53:4481-4485.